Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 20 Mar 2025 for Maxcyte, INC., €1,028. Read the official filing
Filing timeline
BuySaleDavid I. Sandoval
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
David I. Sandoval: trading record in brief
David I. Sandoval appears in our data through filings on Maxcyte, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 15 March 2024 and the latest from 18 March 2025.
On the market, this insider has only sold: 2 sales, €21k in total. Other entries cover 2 share grants. So far in 2025, the count stands at no purchases and 2 sales.
The record was last updated on 20 March 2025 with an open-market sale (€1,028) in Maxcyte, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David I. Sandoval
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
353 shares@ US$3.17934.9% of flowCommon StockSEC:0000905148-25-000985:0
23,125 shares0Common StockSEC:0000905148-25-000963:0
4,466 shares@ US$4.539195.1% of flowCommon StockSEC:0000905148-25-000092:0
3,913 shares0Common StockSEC:0001415889-24-008638:0
4 of 4 declarations
